{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:53:12Z","timestamp":1792666392521,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K27865"],"award-info":[{"award-number":["JP23K27865"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24fk0108709"],"award-info":[{"award-number":["JP24fk0108709"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01373-4","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:07:23Z","timestamp":1768486043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Maternal safety outcomes of respiratory syncytial vaccination during pregnancy with a large-scale database"],"prefix":"10.1038","volume":"11","author":[{"given":"Taito","family":"Kitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Sado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhisa","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"1373_CR1","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 399, 2047\u20132064 (2022).","journal-title":"Lancet"},{"key":"1373_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","volume":"388","author":"B Kampmann","year":"2023","unstructured":"Kampmann, B. et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N. Engl. J. Med. 388, 1451\u20131464 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1373_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","volume":"386","author":"LL Hammitt","year":"2022","unstructured":"Hammitt, L. L. et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N. Engl. J. Med. 386, 837\u2013846 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1373_CR4","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1093\/infdis\/jiae581","volume":"231","author":"SA Madhi","year":"2025","unstructured":"Madhi, S. A. et al. A Phase 1b\/2a trial of a half-life extended respiratory syncytial virus neutralizing antibody, Clesrovimab, in healthy preterm and full-term infants. J. Infect. Dis. 231, e478\u2013e487 (2025).","journal-title":"J. Infect. Dis."},{"key":"1373_CR5","doi-asserted-by":"publisher","first-page":"e747","DOI":"10.1016\/S1473-3099(24)00455-9","volume":"24","author":"J Terstappen","year":"2024","unstructured":"Terstappen, J. et al. The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access. Lancet Infect. Dis. 24, e747\u2013e761 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1373_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(24)01699-4","volume":"404","author":"C Pecenka","year":"2024","unstructured":"Pecenka, C. et al. Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children. Lancet 404, 1157\u20131170 (2024).","journal-title":"Lancet"},{"key":"1373_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","volume":"72","author":"KE Fleming-Dutra","year":"2023","unstructured":"Fleming-Dutra, K. E. et al. Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023. MMWR Morb. Mortal. Wkly Rep. 72, 1115\u20131122 (2023).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"1373_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003540","volume":"6","author":"C Dodd","year":"2021","unstructured":"Dodd, C. et al. Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions. BMJ Glob. Health 6, e003540 (2021).","journal-title":"BMJ Glob. Health"},{"key":"1373_CR9","doi-asserted-by":"publisher","first-page":"e2419268","DOI":"10.1001\/jamanetworkopen.2024.19268","volume":"7","author":"M Son","year":"2024","unstructured":"Son, M. et al. Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes. JAMA Netw. Open 7, e2419268 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1373_CR10","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/LBR.0000000000000572","volume":"26","author":"AS Sagar","year":"2019","unstructured":"Sagar, A. S., Bashoura, L., Nasim, F. & Grosu, H. B. Assessing the safety of rare events: the importance of sample size. J. Bronchol. Inter. Pulmonol. 26, e30 (2019).","journal-title":"J. Bronchol. Inter. Pulmonol."},{"key":"1373_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/2396987320910047","volume":"5","author":"PJ Godolphin","year":"2020","unstructured":"Godolphin, P. J. et al. Outcome assessment by central adjudicators in randomised stroke trials: simulation of differential and non-differential misclassification. Eur. Stroke J. 5, 174\u2013183 (2020).","journal-title":"Eur. Stroke J."},{"key":"1373_CR12","volume":"5","author":"EW Phijffer","year":"2024","unstructured":"Phijffer, E. W. et al. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes. Cochrane Database Syst. Rev. 5, CD015134 (2024).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1373_CR13","unstructured":"Centers for Disease Control and Prevention and Advisory Committee on Immunization Practices (ACIP). RSVpreF vaccine, preterm birth, and small for gestational age at birth preliminary results from the vaccine safety Datalink. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-10-23-24\/03-RSV-Mat-Peds-DeSilva-508.pdf (2024)."},{"key":"1373_CR14","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/j.ajog.2025.04.067","volume":"233","author":"TYJ Hsieh","year":"2025","unstructured":"Hsieh, T. Y. J., Wei, J. C. & Collier, A. R. Investigation of maternal outcomes following respiratory syncytial virus vaccination in the third trimester: insights from a real-world United States electronic health records database. Am. J. Obstet. Gynecol. 233, e181\u2013e190 (2025).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1373_CR15","doi-asserted-by":"publisher","first-page":"e2460735","DOI":"10.1001\/jamanetworkopen.2024.60735","volume":"8","author":"CA Blauvelt","year":"2025","unstructured":"Blauvelt, C. A. et al. Respiratory syncytial virus vaccine and nirsevimab uptake among pregnant people and their neonates. JAMA Netw. Open 8, e2460735 (2025.","journal-title":"JAMA Netw. Open"},{"key":"1373_CR16","doi-asserted-by":"publisher","unstructured":"Torres-Torres, J. et al. Maternal RSV vaccination for infant protection: a systematic review and meta-analysis of phase 3 trials with an integrated economic evaluation. Int J Gynaecol Obstet. https:\/\/doi.org\/10.1002\/ijgo.70641 (2025).","DOI":"10.1002\/ijgo.70641"},{"key":"1373_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/diagnostics15010057","volume":"15","author":"G Kurmanova","year":"2024","unstructured":"Kurmanova, G. et al. Post COVID-19 impact on perinatal outcomes. Diagnostics 15, 57 (2024).","journal-title":"Diagnostics"},{"key":"1373_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.18203\/2320-1770.ijrcog20220153","volume":"11","author":"J Rahman","year":"2022","unstructured":"Rahman, J. & Pervin, S. Maternal complications and neonatal outcomes in oligohydramnios. Int. J. Reprod. Contracept. Obstet. Gynecol. 11, 310\u2013314 (2022).","journal-title":"Int. J. Reprod. Contracept. Obstet. Gynecol."},{"key":"1373_CR19","doi-asserted-by":"publisher","first-page":"126674","DOI":"10.1016\/j.vaccine.2024.126674","volume":"47","author":"M Kemp","year":"2025","unstructured":"Kemp, M., Capriola, A. & Schauer, S. RSV immunization uptake among infants and pregnant persons\u2014Wisconsin, October 1, 2023-March 31, 2024. Vaccine 47, 126674 (2025).","journal-title":"Vaccine"},{"key":"1373_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.15585\/mmwr.mm7431a3","volume":"74","author":"EO Boundy","year":"2025","unstructured":"Boundy, E. O. et al. Respiratory syncytial virus immunization coverage among infants through receipt of nirsevimab monoclonal antibody or maternal vaccination\u2014United States, October 2023-March 2024. MMWR Morb. Mortal. Wkly Rep. 74, 484\u2013489 (2025).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"1373_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/AOG.0000000000005822","volume":"145","author":"C Dugdale","year":"2025","unstructured":"Dugdale, C., Santos, E. & Ciaranello, A. Respiratory syncytial virus vaccination in pregnancy: safety, efficacy, and global implications. Obstet. Gynecol. 145, 144\u2013146 (2025).","journal-title":"Obstet. Gynecol."},{"key":"1373_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100829","volume":"38","author":"D Hodgson","year":"2024","unstructured":"Hodgson, D. et al. Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination. Lancet Reg. Health Eur. 38, 100829 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"1373_CR23","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1007\/s11999-008-0346-9","volume":"466","author":"DJ Biau","year":"2008","unstructured":"Biau, D. J., Kern\u00e9is, S. & Porcher, R. Statistics in brief: the importance of sample size in the planning and interpretation of medical research. Clin. Orthop. Relat. Res. 466, 2282\u20132288 (2008).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"1373_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/AOG.0000000000005817","volume":"145","author":"SA Madhi","year":"2025","unstructured":"Madhi, S. A. et al. Preterm birth frequency and associated outcomes from the MATISSE (maternal immunization study for safety and efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine. Obstet. Gynecol. 145, 147\u2013156 (2025).","journal-title":"Obstet. Gynecol."},{"key":"1373_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk, M. B. et al. A global federated real-world data and analytics platform for research. JAMIA Open 6, ooad035 (2023).","journal-title":"JAMIA Open"},{"key":"1373_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70198","volume":"34","author":"E Stein","year":"2025","unstructured":"Stein, E., H\u00fcser, M., Amirian, E. S., Palchuk, M. B. & Brown, J. S. TriNetX dataworks-USA: overview of a multi-purpose, de-identified, federated electronic health record real-world data and analytics network and comparison to the US census. Pharmacoepidemiol. Drug Saf. 34, e70198 (2025).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"1373_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70093","volume":"18","author":"VR Olaker","year":"2025","unstructured":"Olaker, V. R. et al. With big data comes big responsibility: strategies for utilizing aggregated, standardized, de-identified electronic health record data for research. Clin. Transl. Sci. 18, e70093 (2025).","journal-title":"Clin. Transl. Sci."},{"key":"1373_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1516126","volume":"16","author":"RJ Ludwig","year":"2025","unstructured":"Ludwig, R. J. et al. A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX. Front. Pharm. 16, 1516126 (2025).","journal-title":"Front. Pharm."},{"key":"1373_CR29","doi-asserted-by":"publisher","first-page":"333102423116174","DOI":"10.1177\/03331024231161746","volume":"43","author":"HM Crowe","year":"2023","unstructured":"Crowe, H. M., Wesselink, A. K., Hatch, E. E., Wise, L. A. & Jick, S. S. Migraine and risk of hypertensive disorders of pregnancy: a population-based cohort study. Cephalalgia 43, 3331024231161746 (2023).","journal-title":"Cephalalgia"},{"key":"1373_CR30","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/jcm8101625","volume":"8","author":"R Fox","year":"2019","unstructured":"Fox, R., Kitt, J., Leeson, P., Aye, C. Y. L. & Lewandowski, A. J. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J. Clin. Med. 8, 1625 (2019).","journal-title":"J. Clin. Med."},{"key":"1373_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1471-0528.17320","volume":"131","author":"T Elawad","year":"2024","unstructured":"Elawad, T. et al. Risk factors for pre-eclampsia in clinical practice guidelines: comparison with the evidence. BJOG 131, 46\u201362 (2024).","journal-title":"BJOG"},{"key":"1373_CR32","unstructured":"US Department of Health and Human Services and National Institutes of Health. What are the risk factors for preterm labor and birth? https:\/\/www.nichd.nih.gov\/health\/topics\/preterm\/conditioninfo\/who_risk (2023)."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01373-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01373-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01373-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:08:04Z","timestamp":1771344484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01373-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01373-4","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Kitano has received grants from the Japan Foundation for Pediatric Research, Public Promoting Association, and BioM\u00e9rieux. Dr. Tsuzuki received grants from the Japan Society for the Promotion of Science, Japan Science and Technology Agency, Ministry of Health, Labour and Welfare, and the Japan Institute for Health Security, and Honoraria from Gilead Sciences. Dr. Fukuda received a grant from Japan Agency for Medical Research and Development (AMED). Dr. Yoshida received grants from Tauns Laboratories and Mizuho Medy. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}